Corpus ID: 73876198

THE HEPATITIS C TREATMENT PIPELINE REPORT

@inproceedings{Swan2011THEHC,
  title={THE HEPATITIS C TREATMENT PIPELINE REPORT},
  author={T. Swan},
  year={2011}
}
BMS-650032 • BOCEPREVIR • CTS-1027 • DANOPREVIR • GS 9256 GS 9451 • IDX 320 • MK-5172 • TELAPREVIR • TMC435350 • VANIPREVIR VX-985 • NS5A INHIBITORS • AZD7295 • BMS-790052 • BMS-824393 • CF102 GS 5885 • PPI-461 • POLYMERASE INHIBITORS • ABT-333 • ABT-072 • ANA598 BI 207127 • BMS-791325 • FILIBUVIR • IDX184 • IDX375 • INX-189 • PSI-7977 PSI-352938 • RG7128 • RG7348 • TEGOBUVIR • VX-222 • VX-759 CYCLOPHILIN INHIBITORS • DEBIO 025 • SCY-635 • SILIBININ • LEGALON SILYMARIN • CLEMIZOLE • ITX 5061… Expand
13 Citations
Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis.
  • 68
  • PDF
Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt.
  • 31
  • PDF
Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS.
  • N. Ford, K. Singh, +4 authors P. du Cros
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2012
  • 80
  • PDF
...
1
2
...

References

SHOWING 1-10 OF 147 REFERENCES
...
1
2
3
4
5
...